ARTICLE | Clinical News
Dendritic cell-based immunotherapy: Began Phase I study
February 22, 2000 8:00 AM UTC
Northwest Biotherapeutics Inc., Seattle, Wash. Product: Dendritic cell-based immunotherapy Business: Cancer Therapeutic category: Immune stimulation Target: Immune cells Description: Autologous dendr...